Saba Capital Management, L.P. sold HQL
September 19, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 6,989 shares of Abrdn Life Sciences Investors at $14.10 per share, a transaction worth $98.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,989
Price
$14.10
Total value
$98.5K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 19, 2025
Filing dateSeptember 23, 2025
Shares owned after2,879,256
OwnershipIndirect
10b5-1 planNo
AmendedNo